This inventor holds 3 USPTO granted patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2010-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokushima, JP (2012)
- Naruto, JP (2010 - 2013)
Company Filing History:
Years Active: 2010-2013
Title: Kenji Watanabe: Innovator in Pharmaceutical Chemistry
Introduction
Kenji Watanabe is a prominent inventor based in Naruto, Japan, recognized for his contributions to pharmaceutical chemistry. With a total of three patents to his name, Watanabe has made significant advancements in the development of innovative compounds aimed at addressing various health challenges.
Latest Patents
Watanabe's recent patents include notable inventions focused on therapeutic compounds. His first patent describes "Thiazole compounds and their use for inhibiting phosphodiesterase 4, TNF-α, and IL-4," which details novel thiazole compounds capable of inhibiting the activity of phosphodiesterase 4, the production of tumor necrosis factor alpha, and interleukin 4. The compounds are represented by a general formula emphasizing their molecular structure.
The second patent highlights "Aromatic compounds for suppressing the generation of collagen." This invention introduces a novel compound that effectively diminishes collagen generation while exhibiting minimal side effects, making it a safer alternative in therapeutic applications. The structural details of this compound are also encapsulated within a general formula.
Career Highlights
Kenji Watanabe is currently employed at Otsuka Pharmaceutical Company, Limited, where he actively engages in research and development efforts. His work consistently reflects a commitment to innovation in the pharmaceutical sector, focusing on the creation of compounds that can contribute to better healthcare outcomes.
Collaborations
Throughout his career, Watanabe has collaborated with esteemed colleagues, including Nobuaki Ito and Takumi Sumida. These collaborations underscore the team's dedication to advancing medical research and developing new therapeutic solutions.
Conclusion
Kenji Watanabe's inventive contributions to the field of pharmaceutical chemistry mark him as a significant figure in innovation. With his ongoing work at Otsuka Pharmaceutical Company and his impressive portfolio of patents, Watanabe continues to influence the development of effective therapeutic agents, embodying the spirit of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile